Sign up to save your podcasts
Or
Share TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017
Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
22 ratings
Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Neurology in conversation with
View all
JAMA Editors' Summary
127 Listeners
Neurology® Podcast
280 Listeners
NEJM This Week
321 Listeners
Practical Neurology Podcast
33 Listeners
JAMA Clinical Reviews
478 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Medical News
91 Listeners
BMJ Best Practice Podcast
29 Listeners
Neurology Today in 5
21 Listeners
Annals On Call Podcast
176 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
130 Listeners
GPnotebook Podcast
22 Listeners
The Curious Clinicians
365 Listeners
Continuum Audio
74 Listeners